Literature DB >> 12968071

Androgen receptors containing expanded polyglutamine tracts exhibit progressive toxicity when stably expressed in the neuroblastoma cell line, SH-SY 5Y.

D M Avila1, D R Allman, J-M Gallo, M J McPhaul.   

Abstract

The pathogenesis of X-linked spinal and bulbar muscular atrophy (SBMA) has been traced to an expansion of repeated glutamine (Gln) residues within the amino terminus of the human androgen receptor (AR). To examine the mechanisms by which these expanded repeat ARs (Exp-ARs) are toxic to neurons, we have established and characterized a cell culture model by stably transfecting SH-SY 5Y neuroblastoma cells with cDNAs containing either normal AR (81 series; 23 Glns) or Exp-AR (902 series; 56 Glns). At a low passage number, no differences in cell morphology, growth properties, or susceptibility to toxic insults were observed between clones expressing normal AR or Exp-AR. Initially, both types of cultures were found to express similar levels of specific hormone binding in monolayer binding assays. Immunohistochemical studies demonstrated the vast majority of both the normal AR and Exp-AR were localized to the nucleus in the absence and presence of androgen. As the 902 series of clones were propagated, the Exp-AR content in the cells appeared to decline progressively. However, this decrease actually reflects a gradual disappearance of the Exp-AR cell population. No such selection occurred during the propagation of cells expressing the normal AR. This selection against cells expressing physiological levels of Exp-AR occurs in the absence of intracellular aggregates and suggests that mechanisms other than those involving the formation of aggregates underlie the observed toxicity of Exp-ARs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968071     DOI: 10.1177/153537020322800815

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

1.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

2.  Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients.

Authors:  Georg Rüdiger Soukup; Anne-Dorte Sperfeld; Ingo Uttner; Jochen Karitzky; Albert Christian Ludolph; Jan Kassubek; Herbert Schreiber
Journal:  J Neurol       Date:  2009-07-02       Impact factor: 4.849

Review 3.  Androgen regulation of axon growth and neurite extension in motoneurons.

Authors:  Keith N Fargo; Mariarita Galbiati; Eileen M Foecking; Angelo Poletti; Kathryn J Jones
Journal:  Horm Behav       Date:  2008-02-15       Impact factor: 3.587

Review 4.  Proteotoxicity and cardiac dysfunction.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

Review 5.  Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor.

Authors:  L K Beitel; T Scanlon; B Gottlieb; M A Trifiro
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 6.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 7.  Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.

Authors:  Douglas Ashley Monks; Pengcheng Rao; Kaiguo Mo; Jamie Ann Johansen; Gareth Lewis; Michael Quentin Kemp
Journal:  Horm Behav       Date:  2008-01-05       Impact factor: 3.587

8.  Disruption of nongenomic testosterone signaling in a model of spinal and bulbar muscular atrophy.

Authors:  Mathilde Schindler; Christine Fabre; Jan de Weille; Serge Carreau; Marcel Mersel; Norbert Bakalara
Journal:  Mol Endocrinol       Date:  2012-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.